Antiplatelet and Anticoagulation Therapy for Acute Coronary Syndromes
Antiplatelet and Anticoagulation Therapy for Acute Coronary Syndromes
复制标题
DOI：
10.1161/circresaha.114.302737
复制
发表时间：
2014-06-06
影响因子：
20.1
通讯作者：
Harrington, Robert A.
中科院分区：
文献类型：
--
作者：
Bhatt, Deepak L.;Hulot, Jean-Sebastien;Harrington, Robert A.
过去20年见证了几种不同的抗血栓药物治疗急性冠状动脉综合征的引入和消亡。这些化合物的部分评估是它们对血栓形成事件的影响，相对于出血事件的增加程度。本综述将概述支持各种抗血小板和抗凝治疗及其在急性和慢性治疗期对急性冠状动脉综合征和相关疾病患者的联合治疗的数据。
The past 2 decades have witnessed the introduction and demise of several different antithrombotic medications for acute coronary syndromes. Part of the assessment of these compounds has been their effect on thrombotic events relative to the degree of increase in bleeding events. This review will outline the data supporting various antiplatelet and anticoagulant therapies and their combinations in patients with acute coronary syndromes and related disorders in both the acute and chronic phases of therapy.